Product portfolio


Cardiac Solutions from Roche

In CVD management, early detection and timely initiation of appropriate treatment are crucial. As a market leader in cardiac biomarkers, Roche is committed to continuing cardiology research to advance early diagnosis and help improve clinical decisions. clinical decisions.


Be the pioneer and join ABC1000 Program, now!

Discover how ABC (Age, Biomarkers and Clinical history) scores could provide more accurate stroke and bleeding risk stratification for patients with atrial fibrillation.

Found 0 results in